ZNF470 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.238800E-01
Normal-vs-Stage2
1.743430E-01
Normal-vs-Stage3
1.369900E-02
Normal-vs-Stage4
4.016800E-01
Stage1-vs-Stage2
5.900600E-01
Stage1-vs-Stage3
2.338200E-01
Stage1-vs-Stage4
3.731200E-01
Stage2-vs-Stage3
2.436000E-01
Stage2-vs-Stage4
2.718000E-02
Stage3-vs-Stage4
1.215840E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.149800E-01
Normal-vs-AfricanAmerican
6.198400E-01
Normal-vs-Asian
9.307800E-02
Caucasian-vs-AfricanAmerican
3.322200E-01
Caucasian-vs-Asian
3.521200E-01
AfricanAmerican-vs-Asian
1.599230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.660440E-01
Normal-vs-Female
2.749000E-01
Male-vs-Female
2.267800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.391200E-01
Normal-vs-Age(41-60Yrs)
3.627200E-01
Normal-vs-Age(61-80Yrs)
1.386450E-01
Normal-vs-Age(81-100Yrs)
6.779900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.079700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.277500E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.281560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.084240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.190290E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.171980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.813700E-02
Normal-vs-Daily Drinker
1.701650E-01
Normal-vs-Weekly Drinker
1.826580E-01
Normal-vs-Occasional Drinker
2.624400E-01
Normal-vs-Social Drinker
4.745400E-01
Non Drinker-vs-Daily Drinker
8.518200E-01
Non Drinker-vs-Weekly Drinker
4.408400E-01
Non Drinker-vs-Occasional Drinker
2.882600E-01
Non Drinker-vs-Social Drinker
1.701950E-01
Daily Drinker-vs-Weekly Drinker
4.816600E-01
Daily Drinker-vs-Occasional Drinker
3.441200E-01
Daily Drinker-vs-Social Drinker
2.406800E-01
Weekly Drinker-vs-Occasional Drinker
8.306800E-01
Weekly Drinker-vs-Social Drinker
5.876800E-01
Occasional Drinker-vs-Social Drinker
7.055600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.897010E-01
Normal-vs-Grade 2
1.459570E-01
Normal-vs-Grade 3
2.017000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.619400E-01
Grade 1-vs-Grade 3
1.320640E-01
Grade 1-vs-Grade 4
1.897010E-01
Grade 2-vs-Grade 3
4.510400E-01
Grade 2-vs-Grade 4
1.459570E-01
Grade 3-vs-Grade 4
2.017000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.826200E-02
Normal-vs-NonDiabetic
2.249800E-01
Diabetic-vs-NonDiabetic
8.257600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.382000E-03
Normal-vs-NoPancreatitis
1.383650E-01
Pancreatitis-vs-NoPancreatitis
4.062000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.230200E-02
Normal-vs-N1
2.224000E-01
N0-vs-N1
1.742220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.878840E-01
Normal-vs-TP53-NonMutant
4.900000E-01
TP53-Mutant-vs-TP53-NonMutant
1.487570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
